Common antibiotics linked to inflammatory bowel disease risk

Researchers quantified how often antibiotic use triggers inflammatory bowel disease, establishing a measurable harm threshold that could reshape prescribing practices. The finding has immediate implications for clinical guidelines, pharmaceutical liability, and the trillion-dollar costs of treating chronic gut disorders.

Originaltitel: Antibiotic use and inflammatory bowel disease: number needed to harm?